Results 151 to 160 of about 205,069 (305)

Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci   +9 more
wiley   +1 more source

Persistent inpatient delirium associated with increased length of stay and mortality. [PDF]

open access: yesPLoS One
Bradley J   +6 more
europepmc   +1 more source

A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier   +12 more
wiley   +1 more source

Assessing Delirium Vulnerability in Patients Referred to Consultation-Liaison Psychiatry Service: A Cross-Sectional Survey. [PDF]

open access: yesHealth Sci Rep
Khorshidian F   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy